Associated Papers
Droplet microfluidic screening to engineer angiotensin-converting enzyme 2 (ACE2) catalytic activity.
Okal EF et al.
Journal of Biological Engineering, 2025
39901286 (PubMed )
Supplement: 13036_2025_482_MOESM3_ESM.xlsx › table_for_paper
SARS-CoV-2 receptor-binding mutations and antibody contact sites.
Mejdani M et al.
Antibody Therapeutics, 2021
34386694 (PubMed )
Supplement: Supplementary_Table_1_-_RBD-ACE2-Binding-Affinity-Data_tbab015.xlsx › Ordered_by_frequency
Unraveling the stability landscape of mutations in the SARS-CoV-2 receptor-binding domain.
Smaoui MR et al.
Scientific Reports, 2021
33911163 (PubMed )
Supplement: 41598_2021_88696_MOESM1_ESM.pdf
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochemical and Biophysical Research Communications, 2021
Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochemical and Biophysical Research Communications, 2021
A Computational Approach to Evaluate the Combined Effect of SARS-CoV-2 RBD Mutations and ACE2 Receptor Genetic Variants on Infectivity: The COVID-19 Host-Pathogen Nexus.
Ashoor D et al.
Frontiers in Cellular and Infection Microbiology, 2021
34434902 (PubMed )
Supplement: DataSheet_4.xlsx › Sheet1
Select a paper to view details